
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.300 | 0.820 | 0.520 |
Shares | 99.700 | 99.700 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.267 | 17.767 |
Price to Book | 2.993 | 3.804 |
Price to Sales | 2.718 | 5.020 |
Price to Cash Flow | 13.705 | 15.605 |
Dividend Yield | 1.201 | 0.540 |
5 Years Earnings Growth | 6.316 | 13.106 |
Number of long holdings: 97
Number of short holdings: 25
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Gilead | US3755581036 | 3.55 | 108.91 | -1.06% | |
Vericel Corp Ord | US92346J1088 | 3.55 | 40.46 | -2.03% | |
Bio-Techne | US09073M1045 | 3.38 | 48.61 | +0.43% | |
Novartis | CH0012005267 | 3.32 | 95.08 | +1.12% | |
PTC Therapeutics | US69366J2006 | 3.31 | 48.83 | +0.64% | |
Alnylam | US02043Q1076 | 3.25 | 306.09 | +0.50% | |
Bristol-Myers Squibb | US1101221083 | 3.15 | 48.79 | +1.06% | |
Lonza Group | CH0013841017 | 3.12 | 568.60 | -0.11% | |
Vertex | US92532F1003 | 3.01 | 445.43 | +0.76% | |
Arcellx Inc | - | 3.00 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPI Global Income Fund C mth USD he | 16.91B | -0.75 | 3.73 | 4.04 | ||
JPI Global Income Fund D acc USD he | 16.91B | -1.08 | 2.69 | 3.00 | ||
JPI Global Income Fund D mth USD he | 16.91B | -1.08 | 2.65 | 2.98 | ||
Global Income Fund D div USD hedged | 16.91B | -1.09 | 2.67 | 2.97 | ||
JPI Global Income Fund A acc USD he | 16.91B | -0.97 | 3.05 | 3.36 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review